Where Does Parkinson’s Disease Start?

Parkinson’s disease is a progressive neurological disorder that makes movement harder. People may notice symptoms like shaking, stiff muscles and slow steps, but they happen slowly at first.

A new study, published in Nature Neuroscience, offers a surprising clue about where Parkinson’s might begin. Instead of starting only in the brain, researchers found signs that it could start in the kidneys. The team focused on a protein called alpha synuclein, written as α-Syn. This protein is normally present in nerve cells. When it folds the wrong way and clumps, it can harm brain cells. These clumps are often called Lewy bodies.

Here is the big idea: The researchers found α-Syn clumps in kidney tissue, not just in the brain. In samples from people who had Parkinson’s or Lewy body dementia, 10 out of 11 had abnormal α-Syn growth in the kidneys. They also looked at a different group, 20 people with chronic kidney disease who did not have any signs of brain problems. In that group, 17 had similar protein trouble in the kidneys. This points to a possible path. The kidneys may be a place where harmful proteins first build up, then travel to the brain later.

Animal tests supported this idea. In mice with healthy kidneys, injected α-Syn clumps were cleared from the body. In mice with kidney problems, the clumps built up, then spread to the brain. When scientists cut the nerves that connect the kidneys and the brain, this spread did not happen. That detail suggests a travel route through the body’s nerve network. The team also tested the blood. When they lowered α-Syn in the blood, there was less damage seen in the brain. So the bloodstream may be another route to watch.

Like all science, this work has limits. The number of people studied was small. Mice are helpful in research, but they are not people. We need larger human studies across many ages and health backgrounds. Even so, these results are exciting. They point to new ways to find and treat Parkinson’s earlier. If α-Syn in the kidneys or in the blood is part of the story, future treatments might aim to remove or reduce these clumps before they reach the brain.

What does this mean for you right now? If you live with Parkinson’s, this study does not change your current care plan. It does add hope for new options later. If you live with kidney disease, it is another reason to protect your kidney health. That includes regular checkups, managing blood pressure and diabetes, staying active, getting enough sleep, and following advice on medicines that can affect the kidneys. These steps support your whole body, including your brain.

Parkinson’s likely has more than one starting point. Some studies point to the gut, others now point to the kidneys. Think of it like a puzzle, where many pieces connect over time. As researchers learn more, we get closer to earlier tests and better treatments. We will keep watching this science with curiosity and hope for solutions that edge closer to a cure.